Edition:
United Kingdom

Becton Dickinson and Co (BDX.N)

BDX.N on New York Stock Exchange

234.71USD
23 Jan 2018
Change (% chg)

$-2.00 (-0.84%)
Prev Close
$236.71
Open
$236.03
Day's High
$236.70
Day's Low
$234.37
Volume
346,865
Avg. Vol
358,349
52-wk High
$236.74
52-wk Low
$169.23

Select another date:

Fri, Jan 12 2018

BRIEF-BD Statement On FDA Warning Letter For Preanalytical Systems Business Unit

* BD STATEMENT ON FDA WARNING LETTER FOR PREANALYTICAL SYSTEMS BUSINESS UNIT

BRIEF-FDA Issues Warning Letter To Becton Dickinson & Co

* FDA WARNS BECTON DICKINSON & COMPANY OF SIGNIFICANT VIOLATIONS OF THE LAW AS PART OF ONGOING INVESTIGATION INTO LEAD TESTING ISSUES‍​

UPDATE 1-Becton Dickinson's $24 bln takeover of C R Bard set to close after China nod

* Becton had said China approval was last hurdle for deal to close

China commerce ministry conditionally approves Becton Dickinson-C R Bard merger

BEIJING China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard .

China commerce ministry conditionally approves Becton Dickinson-C R Bard merger

BEIJING, Dec 28 China's commerce ministry said on Thursday that it has conditionally approved a merger between U.S. medical equipment supplier Becton Dickinson and its U.S. peer C R Bard.

Becton, Dickinson to divest two product lines for C R Bard buy: FTC

WASHINGTON U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.

UPDATE 1-Becton, Dickinson to divest two product lines for C R Bard buy -FTC

WASHINGTON, Dec 22 U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to satisfy U.S. Federal Trade Commission concerns their proposed $24 billion merger would negatively affect competition.

BRIEF-BD Issues Statement On FTC Clearance Of Bard Acquisition

* EXPECT BARD DEAL WILL CLOSE IN DECEMBER, PENDING APPROVAL BY CHINA MINISTRY OF COMMERCE, SOME OTHER CONDITIONS Source text for Eikon: Further company coverage:

Becton, Dickinson agrees to divest two product lines for C R Bard buy -FTC

WASHINGTON, Dec 22 U.S. medical equipment supplier Becton Dickinson and C R Bard have agreed to divest two product lines to settle U.S. Federal Trade Commission charges that Becton, Dickinson's proposed $24 billion acquisition of Bard would negatively impact competition in those markets, the FTC said on Friday.

BRIEF-Becton Dickinson And Co Says CEO Vincent Forlenza's FY 2017 Total Compensation Was $13.1 Mln

* BECTON DICKINSON AND CO SAYS CHAIRMAN AND CEO VINCENT FORLENZA'S FY 2017 TOTAL COMPENSATION WAS $13.1 MILLION VERSUS $13.9 MILLION IN FY 2016 - SEC FILING Source text: (http://bit.ly/2ktIxQL) Further company coverage:

Select another date: